Aurdan Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.39M Sell
17,300
-1,818
-10% -$424K 1.11% 24
2026
Q1
$4.67M Buy
19,118
+537
+3% +$125K 1.4% 17
2025
Q4
$3.85M Sell
18,581
-329
-2% -$65.1K 1.19% 19
2025
Q3
$3.51M Sell
18,910
-5,370
-22% -$920K 1.12% 22
2025
Q2
$3.71M Sell
24,280
-2,236
-8% -$344K 1.26% 20
2025
Q1
$4.4M Sell
26,516
-10,106
-28% -$1.58M 1.66% 15
2024
Q4
$5.3M Buy
+36,622
New +$5.68M 2.03% 16

Other funds holding JNJ

Aurdan Capital Management's JNJ Position: Q2 2026 in Review

Aurdan Capital Management reduced its Johnson & Johnson (JNJ) stake by 9.5% in Q2 2026, selling an estimated $424K and leaving 17,300 shares worth $4.39M. The position accounts for 1.11% of the portfolio, ranked #24.

Aurdan Capital Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.3M in Q4 2024. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aurdan Capital Management held 17,300 shares of Johnson & Johnson worth $4.39M as of Q2 2026.
  • Aurdan Capital Management sold 1,818 Johnson & Johnson shares in Q2 2026, an estimated $424K.
  • Johnson & Johnson made up 1.11% of Aurdan Capital Management's portfolio in Q2 2026, its #24 holding.
  • Aurdan Capital Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Aurdan Capital Management's Johnson & Johnson position peaked at $5.3M in Q4 2024.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.